| Structure |
Chemical Name |
CAS |
MF |
 |
Formalin solution |
|
|
|
|
50 bp DNAラダー |
|
|
|
|
BATIMASTAT (MMP inhibitor) |
|
|
|
|
Gelatin coating solution (1 mg/mL) |
|
|
|
|
PFI-4 (EPIGENETIC READER DOMAIN inhibitor) |
|
|
![Urea, N-[2-[2-(1,1-diMethylethyl)phenoxy]-3-pyridinyl]-N'-[4-(trifluoroMethoxy)phenyl]-](/CAS/20150408/GIF/870544-59-5.gif) |
Urea, N-[2-[2-(1,1-diMethylethyl)phenoxy]-3-pyridinyl]-N'-[4-(trifluoroMethoxy)phenyl]- |
870544-59-5 |
C23H22F3N3O3 |
|
|
SC-514 (IΚB/IKK inhibitor) |
|
|
 |
BAY-784 |
1631164-24-3 |
C29H26ClF4N3O5S2 |
|
|
AZD7762 (CHK inhibitor) |
|
|
|
|
TBA-354 (anti-tuberculosis) |
|
|
|
|
EVEROLIMUS (MTOR inhibitor) |
|
|
|
|
Blood lipid biochemical test kit |
|
|
|
|
I-BET-762 (GSK525762) (BET inhibitor) |
|
|
|
|
BML-210 (HDAC inhibitor) |
|
|
|
|
BAY11-7082 (IΚB/IKK inhibitor) |
|
|
|
|
KN-93 PHOSPHATE (CAMK Inhibitor) |
|
|
|
|
PONATINIB (SRC-ABL inhibitor) |
|
|
|
|
PC-300 Preservative for in vitro diagnostics |
|
|
![1-Pentanol, 2-[[2-aMino-5-[[(1S)-1-phenylethyl]thio]thiazolo[4,5-d]pyriMidin-7-yl]aMino]-4-Methyl-, (2R)-](/CAS/20150408/GIF/911715-90-7.gif) |
1-Pentanol, 2-[[2-aMino-5-[[(1S)-1-phenylethyl]thio]thiazolo[4,5-d]pyriMidin-7-yl]aMino]-4-Methyl-, (2R)- |
911715-90-7 |
C19H25N5OS2 |
 |
SR8278 |
1254944-66-5 |
C18H19NO3S2 |
|
|
GANT61 (HEDGEHOG/SMOOTHENED Inhibitor) |
|
|
 |
Α-ブンガロトキシン |
11032-79-4 |
C50H70O14 |
|
|
WS3 (IΚB/IKK inhibitor) |
|
|
|
|
Universal antibody dilution |
|
|
|
|
(+)-JQ1 (BRD4 inhibitor) |
|
|
![rel-2,3,4,6-テトラヒドロ-3α*-ヒドロキシ-2,2-ジメチル-4β*-(2-オキソ-1-ピロリジニル)-6-ベンジル-5H-ピラノ[3,2-c]キノリン-5-オン](/CAS/20200611/GIF/139232-80-7.gif) |
rel-2,3,4,6-テトラヒドロ-3α*-ヒドロキシ-2,2-ジメチル-4β*-(2-オキソ-1-ピロリジニル)-6-ベンジル-5H-ピラノ[3,2-c]キノリン-5-オン |
139232-80-7 |
C25H26N2O4 |
|
|
OSELTAMIVIR PHOSPHATE (NEURAMINIDASE Inhibitor) |
|
|
|
|
TEDIZOLID (MAO-A inhibitor) |
|
|
 |
ジフェニルピラリン |
147-20-6 |
C19H23NO |
![2-{[(8S,11R,14S)-2-ベンジル-11-{3-[(ジアミノメチリデン)アミノ]プロピル}-5-[(4-ヒドロキシフェニル)メチル]-8-[4-(イソプロピルアミノ)ブチル]-14-(ナフタレン-2-イルメチル)-3,6,9,12,15,18,23-ヘプタオキソ-1,4,7,10,13,16,19-ヘプタアザシクロトリコサン-20-イル]ホルムアミド}-6-(イソプロピルアミノ)ヘキサンアミド](/CAS/20211123/GIF/1088715-84-7.gif) |
2-{[(8S,11R,14S)-2-ベンジル-11-{3-[(ジアミノメチリデン)アミノ]プロピル}-5-[(4-ヒドロキシフェニル)メチル]-8-[4-(イソプロピルアミノ)ブチル]-14-(ナフタレン-2-イルメチル)-3,6,9,12,15,18,23-ヘプタオキソ-1,4,7,10,13,16,19-ヘプタアザシクロトリコサン-20-イル]ホルムアミド}-6-(イソプロピルアミノ)ヘキサンアミド |
1088715-84-7 |
C62H88N14O10 |
|
|
SRT 1720 (SIRT1 activator) |
|
|
|
|
MI-2 (HISTONE METHYLTRANSFERASE Inhibitor) |
|
|
|
|
TETRABENAZINE (VMAT-2 Inhibitor) |
|
|
|
|
PUROMYCIN DIHYDROCHLORIDE (Puromycin) |
|
|
![N-[(1R,2S,5R)-5-(tert-ブチルアミノ)-2-[(3S)-3-({7-tert-ブチルピラゾロ[1,5-a][1,3,5]トリアジン-4-イル}アミノ)-2-オキソピロリジン-1-イル]シクロヘキシル]アセトアミド](/CAS/20200611/GIF/1286279-29-5.gif) |
N-[(1R,2S,5R)-5-(tert-ブチルアミノ)-2-[(3S)-3-({7-tert-ブチルピラゾロ[1,5-a][1,3,5]トリアジン-4-イル}アミノ)-2-オキソピロリジン-1-イル]シクロヘキシル]アセトアミド |
1286279-29-5 |
C25H40N8O2 |
 |
BDP FL |
165599-63-3 |
C14H14BF2N2O2.H |
|
|
GSH (antioxidant) |
|
|
|
|
ENMD-2076 (FLT3 inhibitor) |
|
|
 |
Eliapixant |
1948229-21-7 |
C22H21F3N4O3S |
|
|
VISMODEGIB (HEDGEHOG/SMOOTHENED INHIBITOR) |
|
|
|
|
PD123319 (RAAS inhibitor) |
|
|
|
|
DEFACTINIB (FAK inhibitor) |
|
|
 |
ヨードフェンプロピット二臭化水素酸塩 |
145196-87-8 |
C15H20BrIN4S |
|
|
OSELTAMIVIR ACID (NEURAMINIDASE Inhibitor) |
|
|
|
|
ABT-737 (BCL-2 inhibitor) |
|
|
 |
4-DIMETHYLAMINO-7-(4-ETHYL-PHENYL)-7H-9-THIA-1,5,7-TRIAZA-FLUOREN-8-ONE |
869802-44-8 |
C19H18N4OS |
|
|
U-104 (CARBONIC ANHYDRASE INHIBITOR) |
|
|
|
|
Immunostaining Permeate (TRITON X-100) |
|
|
 |
2'-デオキシグアノシン-5'-りん酸ジナトリウム |
33430-61-4 |
C10H15N5NaO7P |
|
|
CH5183284 (FGFR inhibitor) |
|
|
|
|
GELDANAMYCIN (HSP90 inhibitor) |
|
|
|
|
WB primary antibody dilution |
|
|
 |
SB-204741 |
152239-46-8 |
C14H14N4OS |
|
|
BREXPIPRAZOLE (DOPAMINE RECEPTOR agonist) |
|
|
|
|
NECROSTATIN-1 (TNF-ALPHA inhibitor) |
|
|
|
|
PD-173955 (BCR-ABL inhibitor) |
|
|
|
|
[oxido-(2,3,4,5,6-pentaphosphonatooxycyclohexyl)oxyphosphoryl] phosphate |
193743-89-4 |
|
 |
1-メチルピロリジン-3-オール |
13220-33-2 |
C5H11NO |
|
|
PRT062607 HCL (SYK inhibitor) |
|
|
|
|
DOXORUBICIN (TOPOISOMERASE inhibitor) |
|
|
|
|
PACLITAXEL (MICROTUBULE ASSOSIATED inhibitor) |
|
|
 |
レルデセムチブ |
1345410-31-2 |
C19H18F2N6O |
 |
TRPM8 Antagonist |
259674-19-6 |
C26H26N2O2 |
|
|
D-LUCIFERIN POTASSIUM SALT (D-luciferin potassium salt) |
|
|
|
|
FIDAXOMICIN (DNA/RNA SYNTHESIS Inhibitor) |
|
|
|
|
ENDOFECTIN HEPG2 Transfection Reagent |
|
|
|
|
PAC-1 (CASPASE Activator) |
|
|
 |
Radiprodil |
496054-87-6 |
C21H20FN3O4 |
|
|
A83-01 (ALK5 inhibitor) |
|
|
|
|
AC-VDQQD-PNA (CASPASE 2 chromogenic substrate) |
|
|
|
|
Extractant P-507 |
|
|
|
|
BREFELDIN A (protein transport inhibitor) |
|
|
 |
銅 クロロフィリン ナトリウム |
28302-36-5 |
C34H29CuN4NaO7(-2) |
 |
CVN417 |
2919851-73-1 |
|
|
|
POLY-D-LYSINE/polylysine |
|
|
|
|
PANOBINOSTAT (LBH589) (HDAC inhibitor) |
|
|
|
|
PLERIXAFOR (CXCR inhibitor) |
|
|
|
|
LINIFANIB (VEGFR inhibitor) |
|
|
|
|
Protein Marker |
|
|
|
|
APIXABAN (FACTOR XA Inhibitor) |
|
|
|
|
BLU-9931 (FGFR inhibitor) |
|
|
 |
2,5-ジフルオロベンゼンスルホニルクロリド |
26120-86-5 |
C6H3ClF2O2S |
|
|
BARDOXOLONE METHYL (IΚB/IKK inhibitor) |
|
|
|
|
RPE-streptavidin conjugate |
|
|
|
|
BAY87-2243 (HIF inhibitor) |
|
|
|
|
BEDAQUILINE (anti-tuberculosis mycobacteria) |
|
|
|
|
Platelet dilution (counting solution) |
|
|
|
|
CNX-774 (BTK inhibitor) |
|
|
 |
ロチラナー |
1369852-71-0 |
C20H14Cl3F6N3O3S |
|
|
YM155 (SURVIVIN inhibitor) |
|
|
|
|
GSK126 (EZH2 inhibitor) |
|
|
|
|
Sodium chloride standard titration solution |
|
|
|
|
Poly-L-Lysine Solution (1 × ) |
|
|
|
|
ヨードフェンプロピット二臭化水素酸塩 |
145196-87-8 |
C15H20BrIN4S |
![N-[3-[(3-アミノプロピル)アミノ]プロピル]-1,4-ブタンジアミン](/CAS/20150408/GIF/70862-11-2.gif) |
N-[3-[(3-アミノプロピル)アミノ]プロピル]-1,4-ブタンジアミン |
70862-11-2 |
C10H26N4 |
|
|
WESTERN Antibody Eluent (Strongly Basic) |
|
|
|
|
Raffinose solution 5% |
|
|
|
|
Skimmed Milk Powder |
|
|
 |
3-Methoxysalicylaldehyde |
|
C8H8O3 |
|
|
COENZYMEA HYDRATE |
|
|